The nuclear receptor LRH ‐1 discriminates between ligands using distinct allosteric signaling circuits
Protein Science · 2023-10 · 32 (10)
DOI: 10.1002/pro.4754 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, online erschienen am 20.09.2023. Verfasst von Suzanne G Mays und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Receptors, Cytoplasmic and Nuclear, Transcription Factors. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, Burroughs Wellcome Fund, National Institutes of Health.
Abstract (Originalsprache)
Nuclear receptors (NRs) are transcription factors that regulate essential biological processes in response to cognate ligands. An important part of NR function involves ligand‐induced conformational changes that recruit coregulator proteins to the activation function surface (AFS), ~15 Å away from the ligand‐binding pocket. Ligands must communicate with the AFS to recruit appropriate coregulators and elicit different transcriptional outcomes, but this communication is poorly understood. These studies illuminate allosteric communication networks underlying activation of liver receptor homolog‐1 (LRH‐1), a NR that regulates development, metabolism, cancer progression, and intestinal inflammation. Using >100 μs of all‐atom molecular dynamics simulations involving 74 LRH‐1 complexes, we identify distinct signaling circuits used by active and inactive ligands for AFS communication. Inactive ligands communicate via strong, coordinated motions along paths through the receptor to the AFS. Activating ligands disrupt the “inactive” circuit and induce connectivity with a second allosteric site. Ligand‐contacting residues in helix 7 help mediate the switch between circuits, suggesting new avenues for developing LRH‐1‐targeted therapeutics. We also elucidate aspects of coregulator signaling, showing that localized, destabilizing fluctuations are induced by inappropriate ligand‐coregulator pairings. These studies have uncovered novel features of LRH‐1 allostery, and the quantitative approach used to analyze many simulations provides a framework to study allosteric signaling in other receptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Emory University, Atlanta, Georgia, USA.
- Department of Genome Biology, Centre for Genomic Regulation, Barcelona, Spain.
- Department of Molecular Biology and Biochemistry, Pennsylvania State University, State College, Pennsylvania, USA.
ORCID-Profile: Suzanne G Mays, Eric A Ortlund, C Denise Okafor
Förderung
- NIDDK NIH HHS
- Burroughs Wellcome Fund
- National Institutes of Health
Zitieren
APA
Mays, S. G., Hercules, D., Ortlund, E. A., & Okafor, C. D. (2023). The nuclear receptor LRH ‐1 discriminates between ligands using distinct allosteric signaling circuits. Protein Science, 32(10). https://doi.org/10.1002/pro.4754
Vancouver
Mays SG, Hercules D, Ortlund EA, Okafor CD. The nuclear receptor LRH ‐1 discriminates between ligands using distinct allosteric signaling circuits. Protein Science. 2023;32(10). doi:10.1002/pro.4754
BibTeX
@article{Mays2023,
author = {Mays, Suzanne G and Hercules, David and Ortlund, Eric A and Okafor, C Denise},
title = {The nuclear receptor LRH ‐1 discriminates between ligands using distinct allosteric signaling circuits},
journal = {Protein Science},
year = {2023},
volume = {32},
number = {10},
doi = {10.1002/pro.4754}
}
EUVIMED